Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signatures

While understanding molecular heterogeneity across patients underpins precision oncology, there is increasing appreciation for taking intra-tumor heterogeneity into account. Based on large-scale analysis of cancer omics datasets, we highlight the importance of intra-tumor transcriptomic heterogen…